CCNL1 and prostate carcinoma: By binding to CYCLINL1 at the m6A site, NEAT1-1 becomes a bridge that connects CYCLINL1 and CDK19 and then phosphorylates pol II Ser2 in the RUNX2 promoter, ultimately promoting the bone metastasis of prostate cancer (PC)58.